Huntington National Bank Deciphera Pharmaceuticals, Inc. Transaction History

Huntington National Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$13.58 - $17.36 $624 - $798	46 Added 7.58%	653 $10,000
Q4 2023 Feb 07, 2024	SELL	$10.11 - $16.54 $101 - $165	-10 Reduced 1.62%	607 $9,000
Q3 2023 Nov 08, 2023	BUY	$12.46 - $15.48 $2,018 - $2,507	162 Added 35.6%	617 $7,000
Q2 2023 Aug 11, 2023	BUY	$13.28 - $15.96 $6,042 - $7,261	455 New	455 $6,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

Stay updated on Huntington National Bank with notifications on news.